YIBAI PHARMACEUTICAL: Loss of 19.9021 million yuan in the first half of the year

YIBAI PHARMACEUTICAL disclosed its 2025 semi-annual report on the evening of August 20. The company achieved operating revenue of 993 million yuan in the first half of the year, a year-on-year decrease of 14.99%; the net profit attributable to the parent company was a loss of 19.9021 million yuan, compared to a loss of 106 million yuan in the same period last year. During the reporting period, the sales of the company's main products decreased, but the amount of cost and expenses still exceeded the revenue; compared to the same period last year, due to the company's strengthened expense control and enhanced cost reduction and efficiency improvement during this reporting period, the decrease in cost and expenses was greater than the decrease in revenue, resulting in a reduction in the current period's loss